In human immunodeficiency virus and acquired immune deficiency syndrome 23 (HIV/AIDS) patients with very low CD4 cell counts, there is a temporal relationship 24 between administration of antiretroviral therapy (ART) and an increased inflammatory 25 response state known as the immune reconstitution inflammatory syndrome (IRIS). The 26 predominant clinical presentation of IRIS is an infectious disease that can be life-27
threatening. IRIS-related infectious events are distributed similarly between adult males 28 and females, albeit a few studies have shown a skewing towards the male sex in 29 pediatric IRIS. Here, we assessed sex-specific differences in the causes and extent of 30 IRIS infectious events in HIV-infected pediatric patients on ART. We carried out a 31 prospective clinical analysis (from 2000 to 2018) of IRIS-related infectious events after 32
ART in a cohort of 82 Brazilian children and adolescents infected with HIV-1 through 33 mother-to-child transmission as well as a comprehensive cross-referencing with public 34 records on IRIS-related infectious causes in pediatric HIV/AIDS. Twelve events 35
fulfilling the criteria of IRIS occurred exclusively in eleven females in our cohort. The 36 median age at IRIS events was 3.6 years. The infectious causes included 37
Mycobacterium bovis, varicella-zoster virus, molluscum contagiosum virus, human 38 papillomavirus, cytomegalovirus, and Mycobacterium tuberculosis. In one female, there 39 was regional bacillus Calmette-Guérin dissemination and cytomegalovirus esophagitis. 40
There was complete health recovery after ten IRIS events without the use of 41 corticosteroids or ART interruption. One case of IRIS-associated miliary tuberculosis 42 was fatal. The biological female sex was a significant risk factor for IRIS events (odds 43 ratio: 23.67; 95% confidence interval 95%: 1.341 -417.7; P = 0.0016). We observed an 44 effect of the advanced HIV/AIDS variable in IRIS females as compared with non-IRIS 45 females (mean CD4 + T cell percentage 13.36% versus 18.63%; P = 0.0489), 46 underpinning the exclusively skewed distribution towards the female sex of this cohort. 47 Moreover, the IRIS females in our cohort had higher mean CD4 + T cell percentages 48 before (13.36%) and after IRIS (26.56%) than those of the IRIS females (before IRIS, 49 4.978%; after IRIS, 13.81%) in previous studies conducted worldwide. We concluded 50 that the exclusively skewed distribution of pediatric IRIS towards females is associated 51 with more advanced AIDS. 52
Introduction

54
Rigorous adherence to antiretroviral therapy (ART) leads to recovery from 55 immunodeficiency and results in a rapid decrease in morbidity and mortality rates 56 among human immunodeficiency virus (HIV)-1 infected patients. In ART patients with 57 very low CD4 cell percentages (CD4%), there is a temporal relationship between 58 therapy and an increased inflammatory response state known as the immune 59 reconstitution inflammatory syndrome (IRIS), occurring a few weeks to months after 60 therapy administration. Fernandes and Medina-Acosta, 2010). 109
Ethical considerations 110
The study received approval (FR-405294) from the Regional Committee of Ethics in 111
Research in Humans from the Faculty of Medicine of Campos. All legally authorized 112 next-of-kin gave written informed consent on behalf of participants in compliance with 113 the Declaration of Helsinki. Clinical examination was performed by only one infectious 114 disease specialist pediatrician (RC). The follow-up was performed monthly or whenever 115 the clinical condition demanded. 116
Antiretroviral therapy 117
ART was provided universally for infants with confirmed HIV infection during the first 118
year of life and for children or adolescents with moderate or severe clinical 119 manifestations or immunodepression (CD4% < 25%), following the recommendations 120
of the Brazilian Ministry of Health (Brazil, 2009). It is of note that during the 18 years 121 of the study, different ART regimens were implemented according to the national 122 treatment guidelines. 123
Definition criteria of IRIS 124
We used the major and minor criteria for IRIS listed by French and colleagues (French 125 et al., 2004); cases required compliance with the two major criteria or one major 126 criterion plus two minor criteria for inclusion. The major criteria are (i) atypical 127 presentation of opportunistic infections or tumors in patients responding to ART and (ii) 128 decrease in plasma HIV RNA concentration by > 1 log copies/mL. The minor criteria 129 are (i) increase in blood CD4% after ART, (ii) increase in an immune response specific 130 to the relevant pathogen, and (iii) spontaneous resolution of the infectious episode 131 without specific antimicrobial therapy or tumor chemotherapy with the continuation of 132 ART (French et al., 2004). 133
Estimates of X-chromosome inactivation 134
Genomic DNA samples were extracted from peripheral blood of females with IRIS-135 related infectious events. The extent of X-chromosome inactivation (XCI) was then 136 estimated by interrogating the 5 me CpG epigenetic marks neighboring short tandem 137 repeats localized in the promoter regions of either the X-linked retinitis pigmentosa RP2 138 gene (Xp region) or the androgen receptor AR gene (Xq region), as we had previously 139
reported (Machado et al., 2014) . 140
Searching relevant cases via PubMed 141
We carried out a literature review following the Preferred Reporting Items for 142 Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines ( adherence to ART and with pulmonary TB that was treated earlier, presented with 186 weight loss, cervical adenopathies, respiratory distress, and miliary radiological pattern 187 after 14 days of supervised ART, which progressed to death in three days. Lastly, a 10-188
year-old female was diagnosed with bacterial pneumonia nine days after commencing 189
ART. At home, she was treated with penicillin and developed fever, respiratory distress, 190
weight loss, and bilateral lung infiltrates after 60 days, requiring hospitalization. She 191 had a negative tuberculin test result, albeit household TB contact was reported. She was 192 then treated with rifampicin, isoniazid, and pyrazinamide with complete recovery. 193
In total, we observed 11 episodes of unmasked IRIS and one of paradoxical IRIS. When 194 comparing viral loads (Figure 1A , B) and CD4% ( Figure 1C, D) , females with IRIS had 195 significantly (P = 0.0489) lower CD4 values than those of non-IRIS females and viral 196 loads were similar to those of non-IRIS females and males (Figure 1) . 197
The exclusively skewed occurrence of IRIS-related infectious events towards pediatric 198 females is intriguing. Therefore, we investigated a possible association between 199 extremely skewed female sex distribution of IRIS manifestations and affected females 200 exhibiting highly skewed XCI. We only had genomic DNA samples available from six 201 female patients for the XCI assay. Notably, only one affected female exhibited a 202 preferential (> 90%) XCI (Supplementary Figure S1) . 203
IRIS-related infectious events in pediatric HIV/AIDS reported in the literature 204
The literature search yielded 169 publications, but only 40 studies passed our 205 requirements for listing relevant cases ( Supplementary Table S2 ). In total, we listed 127 206
HIV 11.8% (10/85) of cases, the viral load was undetectable. When restricting the analysis to 224 female subsets from the compilation and our cohort, the viral loads were found 225 decreased in both subgroups (Figure 2A, B) . 226
Before the onset of IRIS, 85.7% (96/112) of the reported cases had CD4 cell counts < 227
200 cells/mL (< 15%). After IRIS, CD4 cell counts increased to 200-499 (> 15%) in 228 40.4% (40/99) of the cases. When the female subsets were compared, we noted that the 229 compilation subset had significantly lower CD4 counts (P = 0.0002) than that of our 230 cohort and that there was an increase in CD4% in both groups (Figure 2C, D) . The IRIS 231 females of our cohort had higher mean CD4 + T cell percentages before (13.36%) and 232 after IRIS (26.56%) than those of the IRIS females (before IRIS, 4.9%; after IRIS, 233 13.8%) in previous studies conducted worldwide. Interestingly, the IRIS females in the 234 literature have more advanced HIV/AIDS than the IRIS females of our cohort. 235
Discussion
236
We identified an abnormal distribution, fully skewed towards the female sex, of IRIS-237 related infectious events in HIV-infected Brazilian children and adolescents on ART. 238 We observed 12 episodes in 11 females and none in males during a study period of 18 239 years. The bulk of clinical data allowed us to suggest that the observed skewed 240 distribution towards the female sex is due to more advanced HIV/AIDS in these females ., 2005) ). The IRIS females in our cohort had higher mean CD4 + 249 T cell percentages before and after IRIS than those of the IRIS females in previous 250 studies conducted worldwide. 251
Sex-biased susceptibility to bacterial infections has been linked to the differential 252 effects of sex steroid hormones (estrogen and testosterone) on innate immunity (Garcia-253 Gomez et al., 2013); for example, males are more susceptible to TB than females (Stival 254 et al., 2014) . A caveat against sex hormones being involved in female-biased 255 presentation of IRIS in our cohort is the fact that none of the males presented with IRIS. 256 Unfortunately, we did not measure sex hormones in the 11 affected females at the time 257 of IRIS events and it is thus unclear whether abnormal sex hormone levels are 258 implicated in female-biased IRIS manifestations. We did investigate, however, whether 259 this skewed IRIS event distribution towards females was associated with highly skewed 260 XCI. A significant number of immune-associated genes map to the X-chromosome 261
( presentation of CMV disease in HIV-infected adults (Wilcox, 1999 ) and there appears 275
to be a functional association between IRIS and esophageal stricture observed in CMV 276 infection cases (Wilcox, 1999) . To our knowledge, we report the first pediatric case of 277 esophageal stricture secondary to CMV infection related to IRIS; moreover, CD4% 278 during the IRIS event was > 25, corroborating the view that CD4% is not a reliable 279 marker for disease progression and severity in infants. 280
IRIS-related infectious events should be considered important contributors to higher 281
mortality rates in resource-limited settings with a late introduction of ART (Davies and  282 Meintjes, 2009). Very early ART administration is an essential preventive factor against 283 an IRIS-related fatal outcome (Rabie et al., 2011) . Furthermore, IRIS-related infectious 284 events are more life-threatening at an early age (Smith et al., 2009 ). In our cohort, six 285 IRIS-related episodes occurred at less than one year of age. None of the 11 females 286
were treated with corticosteroids and all remained on ART. Recovery was completed in 287 10 females, but there was a fatal case for a 16-year-old patient (mortality of 8.3%). 288
The prevalence of reported IRIS-related infectious events varied greatly by country or 289 geographical region; 4.7% of the cases were reported in South Africa ( It is unclear whether differential (epi)genetic components can partly account for the 298 disparity in distribution. Sex-stratified genome-wide association studies of IRIS using 299 multiethnic genotyping arrays are needed to appraise the differences in disease 300 susceptibility and to identify candidate autosomal and X-linked loci in diverse and 301 admixed populations. 302
In conclusion, our prospective study found that IRIS-related infectious events occurred 303 exclusively in females in a cohort of 80 HIV-infected Brazilian children and adolescents 304 on ART. This complete skewing towards the female sex is uncommon and was linked to 305 more advanced HIV/AIDS. 306
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Figure Legends
in females presenting with IRIS-related infectious events (represented in pink), females 488 with no IRIS events (yellow), and males (green). Females presenting with IRIS 489 infectious events exhibited lower CD4 cell percentages before (C) but not after ART 490 (D). 491 presented lower CD4 cell percentages (E) than the females with IRIS in our cohort (F). 499 Table 1 . Characteristics of clinical manifestations and staging, laboratory findings, 500 therapeutic approach, and evolution of patients with IRIS. 501 502   Table S1 . Clinical staging, classification, and monitoring characteristics for HIV/AIDS 503 pediatric patients who did not present with IRIS-related infectious events in our cohort. 504 Table S2 . PubMed-based compilation of IRIS-related infectious events in children and 505 adolescents infected with HIV (January 1 st , 1979 through August 30 th , 2018). 506 Figure S1 . Rates of X-chromosome inactivation (XCI) in six females presenting with 507 IRIS-related infectious events. The percentage of XCI was determined by genotyping 508 genomic DNA with the two highly polymorphic short tandem repeat loci located in the 509 AR and RP2 genes (Machado et al., 2014) to identify heterozygotes. Both AR and RP2 510 genes escape XCI and thus in females with random XCI, the rate of X-chromosome 511 active (Xa) over X-chromosome inactive (Xi) is approximately 50%. The figure depicts 512
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the Xa/Xi rate (in percentage) observed for the AR and RP2 marker systems. Only one 513 female sample exhibited a highly skewed rate of XCI (> 90%). 514
